One of America’s most cherished health beliefs is being upended: could running marathons actually raise your risk of colon cancer if you’re under 50?
Story Highlights
- A new clinical study links extreme endurance running to higher rates of advanced colon cancer precursors in younger adults.
- Findings challenge the long-held idea that intense exercise always protects against cancer.
- Researchers found 15% of high-volume runners had advanced adenomas, compared to just 1–2% in the general population.
- The study urges reconsideration of screening guidelines for athletes and sparks debate in the medical community.
The Marathon Myth Under Scrutiny: Unexpected Cancer Risk Emerges
Dr. Tim Cannon and a team at Inova Schar Cancer Institute have revealed unsettling results from their latest prospective study: marathon and ultramarathon runners between 35 and 50 face a surprisingly high rate of advanced colon adenomas. Adenomas are precancerous growths, and their presence signals a brewing problem that most runners never considered. The research, spanning 2022 to 2024, enrolled 100 dedicated runners—individuals who completed at least five marathons or two ultramarathons—none of whom had family histories or known inflammatory risk factors.
The most provocative statistic: 15% of these athletes harbored advanced adenomas, and 41% had at least one adenoma detected during screening. For context, the expected rate in the general population hovers around 1–2% for advanced adenomas and well below 10% for any adenoma in this age group. The findings, presented at the ASCO Annual Meeting in August 2025, ignited a firestorm of debate among oncologists, sports medicine experts, and the running community. Many questioned whether the rigorous physical demands of extreme running could actually trigger harmful changes in the gut.
Gut Stress and the Hidden Perils of Endurance Sports
Repeated physical stress on the gastrointestinal tract is a known consequence of long-distance running, often resulting in “runner’s colitis”—temporary, usually benign inflammation and bleeding. But the Inova study raises a more serious question: could chronic, repetitive gut injury set the stage for cancer development in otherwise healthy, athletic adults? Researchers suspect that the hypoxia (oxygen deprivation) and inflammation triggered by hours of pounding pavement might foster mutagenesis, increasing the odds that precancerous lesions will emerge and progress.
Dr. Cannon has publicly called for a reevaluation of screening protocols for endurance athletes, especially those experiencing rectal bleeding after runs. He warns that while exercise is widely protective against most cancers, there may be a threshold beyond which benefits reverse, particularly for the colon. The medical community is now split: some experts urge caution and more research before revising guidelines, while others assert that the alarming adenoma rates seen in this cohort demand immediate attention and heightened vigilance.
Rethinking Screening and Prevention: Who Is at Risk?
This study arrives as cases of early-onset colorectal cancer continue to climb, prompting the U.S. to lower routine screening age from 50 to 45 in 2021. Yet, the Inova data suggest that some populations—namely, high-volume runners—may require even earlier and more aggressive surveillance. Runners in their 30s and 40s, often considered the picture of health, are now advised to monitor for symptoms like persistent rectal bleeding, unexplained fatigue, or changes in bowel habits. The American Society of Clinical Oncology and other medical societies are actively reviewing these results, weighing the benefits and risks of broader screening in athletic populations.
Critics caution against overgeneralizing the study’s implications, noting its preliminary, non-peer-reviewed status and the relatively small sample size. They emphasize that regular exercise remains one of the most effective tools for cancer prevention overall. However, the possibility that the very activities lauded for building health could, in rare cases, sow the seeds of disease is forcing healthcare providers, athletes, and insurers alike to reconsider long-held assumptions. The study has prompted calls for larger, multi-center research to confirm the findings and explore the underlying mechanisms in greater detail.
Sources:
